Molecular Diagnostics for Tropical Infectious Diseases

A special issue of Tropical Medicine and Infectious Disease (ISSN 2414-6366). This special issue belongs to the section "Infectious Diseases".

Deadline for manuscript submissions: 31 August 2026 | Viewed by 1324

Special Issue Editors


E-Mail
Guest Editor
1. Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey 64700, Mexico
2. Massachusetts Institute of Technology (MIT), Room 36-886, 32 Vassar St, Cambridge, MA 02139, USA
Interests: molecular diagnostics; nucleic acid amplification; isothermal amplification; microfluidics; portable diagnostic devices; lab-on-a-chip

E-Mail Website
Guest Editor
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León, 64460 Monterrey, Mexico
Interests: nucleic acid amplification; next-generation sequencing (NGS); multiplex assay; molecular diagnostics; fluorescent detection

Special Issue Information

Dear Colleagues,

Tropical infectious diseases predominantly occur in regions located between the Tropics of Cancer and Capricorn, particularly in developing and underdeveloped countries. These diseases are responsible for approximately 15 million deaths each year and are closely associated with inadequate housing, malnutrition, and weak healthcare systems. The causative agents include parasites (Malaria, Chagas disease, Leishmaniasis, etc.), viruses (Dengue, Zika, Chikunguya, and Ebola, etc.), bacteria (Tuberculosis, Leprosy, Typhoid Fever, etc.), and fungi (Histoplasmosis, Coccidioidomycosis, Sporotrichosis, etc.).

Of growing concern is the fact that tropical diseases are no longer confined to tropical regions. Increased global migration, tourism, and work-related travel have facilitated their spread to non-endemic areas, with individuals with no travel history but who may reside near international airports or have contact with infected travelers acting as vectors. Furthermore, several of these diseases do not present early symptoms, as infectious agents have long incubation periods, sometimes extending for years or even decades, further hampering early detection and control efforts.

Considering these challenges, there is a critical need for advanced molecular diagnostic tools characterized by high sensitivity and specificity. These tools, which enable the direct detection of nucleic acids (DNA or RNA) and pathogen-specific proteins, are essential for the early identification of infections. Accurate and timely diagnosis not only facilitates appropriate clinical management and treatment but also plays a pivotal role in epidemiological surveillance, the containment of disease spread, and reduction in associated mortality.

One of the most widely used techniques for nucleic acid detection is PCR, employed due to its high sensitivity. However, in recent years, alternative methods based on the same principle of nucleic acid amplification have been developed. These methods offer advantages such as single-temperature incubation, enabling portability and reducing infrastructure costs. Some of these isothermal amplification techniques include LAMP (loop-mediated isothermal amplification), RPA (recombinase polymerase amplification), HDA (helicase-dependent amplification), and PSR (polymerase spiral reaction), among others.

Similarly, a variety of protein detection methods have been developed following the same principles of portability and simplicity. These include lateral flow assays and advanced immunoassays, integrated with lab-on-a-chip devices, such as biosensors and microfluidic platforms.

These nucleic acid and protein detection techniques are increasingly being explored for point-of-care diagnostics and field-deployable molecular testing due to their simplicity and minimal equipment requirements.

Therefore, in this Special Issue, we welcome the submission of review articles and original research papers focusing on novel molecular diagnostic techniques for detecting DNA, RNA, or proteins of infectious agents responsible for tropical diseases, as well as their potential applications.

Dr. Everardo González-González
Dr. Elda Ariadna Flores-Contreras
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tropical diseases
  • infectious agents
  • early detection
  • molecular diagnostics
  • PCR
  • isothermal amplification
  • POC
  • loop-mediated isothermal amplification (LAMP)
  • recombinase polymerase amplification (RPA)
  • helicase-dependent amplification (HDA)
  • lateral flow assay (LFA)

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Other

8 pages, 260 KB  
Brief Report
Diagnostic Performance of Two Commercial qPCR Kits for Leptospira spp. Detection
by Andrés Esteban Barragán-Peña, Darwin Paredes-Núñez, Fabiola Jimenez Valenzuela, Solon Alberto Orlando, Elsy Carvajal, Angel Sebastian Rodriguez-Pazmiño and Miguel Angel Garcia-Bereguiain
Trop. Med. Infect. Dis. 2026, 11(5), 119; https://doi.org/10.3390/tropicalmed11050119 - 30 Apr 2026
Viewed by 457
Abstract
Early confirmation of leptospirosis is essential for prompt antimicrobial treatment, and PCR-based diagnosis has been reported as a highly sensitive method during the acute phase in the first week since the symptom’s onset. We evaluated the diagnostic performance of two commercial real-time PCR [...] Read more.
Early confirmation of leptospirosis is essential for prompt antimicrobial treatment, and PCR-based diagnosis has been reported as a highly sensitive method during the acute phase in the first week since the symptom’s onset. We evaluated the diagnostic performance of two commercial real-time PCR assays—Viasure Leptospira Real-Time PCR (Certest Biotec, Spain) and Genesig Advanced Leptospira spp. (Primerdesign, UK) against an in-house qPCR assay targeting lipL32 as the reference method. A retrospective comparative evaluation was conducted on 235 human EDTA-blood samples obtained during the acute phase of clinical presentation suspected of leptospirosis. The in-house qPCR reference assay detected 55 positive and 180 negative samples, and both commercial kits accurately classified every specimen, achieving 100% sensitivity (95% CI: 93.5–100), 100% specificity (95% CI: 98.0–100), and 100% overall accuracy. In conclusion, both commercial qPCR kits offer high accuracy for the early detection of pathogenic Leptospira in human blood samples. Full article
(This article belongs to the Special Issue Molecular Diagnostics for Tropical Infectious Diseases)
9 pages, 207 KB  
Brief Report
Prevalence of Neurosyphilis in Patients with Acute Ischemic Stroke: A Cross-Sectional Screening Study in Thailand
by Chumpol Anamnart and Nawanwat Tepkidakarn
Trop. Med. Infect. Dis. 2026, 11(5), 117; https://doi.org/10.3390/tropicalmed11050117 - 29 Apr 2026
Viewed by 362
Abstract
Meningovascular syphilis, a type of neurosyphilis, causes stroke and various types of myelopathy. In recent years, there has been an increase in the incidence of neurosyphilis. However, diagnosing neurosyphilis remains challenging due to the reliance on serum and cerebrospinal fluid (CSF) testing, which [...] Read more.
Meningovascular syphilis, a type of neurosyphilis, causes stroke and various types of myelopathy. In recent years, there has been an increase in the incidence of neurosyphilis. However, diagnosing neurosyphilis remains challenging due to the reliance on serum and cerebrospinal fluid (CSF) testing, which has low specificity and sensitivity. Magnetic resonance vessel wall imaging (MR-VWI), recently developed to identify vessel wall pathologies, may aid in diagnosing neurosyphilis. In this cross-sectional study, we performed systematic screening for syphilis in all 366 patients with acute ischemic stroke or transient ischemic attack admitted to our stroke unit. Further CSF analysis and MR-VWI were specifically conducted only on those with reactive serum venereal disease research laboratory (VDRL) or treponema pallidum particle hemagglutination assay (TPHA) tests to evaluate neurosyphilis. Serum screening was reactive in 5.7% (21/366) of patients; among these, the prevalence of likely neurosyphilis (defined by abnormal CSF pleocytosis or protein levels) was 2.2% (8/366). Within this group of eight patients, MR-VWI was technically feasible and thus performed in six cases. Although all CSF-VDRL tests were non-reactive, MR-VWI identified diagnostic evidence of meningovascular syphilis (concentric wall thickening and enhancement) in 33.3% (2/6) of symptomatic patients who underwent the scan. Neurosyphilis remains a critical, treatable cause of stroke that can affect older patients with established vascular risk factors. Our findings demonstrate that routine serum screening is essential, as traditional CSF-VDRL tests may yield false-negative results. MR-VWI serves as a valuable adjunct tool to provide objective evidence of active vasculitis, guiding the initiation of appropriate antibiotic therapy when laboratory results are inconclusive. Full article
(This article belongs to the Special Issue Molecular Diagnostics for Tropical Infectious Diseases)
Back to TopTop